Interim considerations for infection prevention and control of coronavirus disease 2019 (COVID-19) in inpatient obstetric healthcare settings
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Interim considerations for infection prevention and control of coronavirus disease 2019 (COVID-19) in inpatient obstetric healthcare settings
Filetype[PDF-69.28 KB]


Details:
    1. Filetype[PDF - 129.62 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      February 16, 2020
      Description:
      This document offers guidance on how to optimize supplies of N95 filtering facepiece respirators (commonly called “N95 respiratorsâ€) in healthcare settings in the face of potential ongoing coronavirus disease 2019 (COVID-19) transmission in the U...
      File Type:
      Filetype[PDF - 129.62 KB]
    2. Filetype[PDF - 71.24 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      February 16, 2020
      Series:
      Coronavirus disease 2019 (COVID-19)
      Description:
      Who this is for: Healthcare providers and public health officials managing patients with coronavirus disease (COVID-19).What this is for: To help prevent the spread of COVID-19 in healthcare facilities.How to use: Reference to guide healthcare staff ...
      File Type:
      Filetype[PDF - 71.24 KB]
    3. Filetype[PDF - 56.77 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      February 17, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      File Type:
      Filetype[PDF - 56.77 KB]
    4. Filetype[PDF - 41.34 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division.
      Published Date:
      6 de febrero de 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      Interim guidance for preventing the spread of coronavirus disease 2019 (COVID-19) in homes and residential communitiess [Spanish]1 de febrero de 2020Esta guía interina se basa en lo que actualmente se sabe sobre el nuevo coronavirus 2019 (2019-nCoV)...
      File Type:
      Filetype[PDF - 41.34 KB]
    5. Filetype[PDF - 135.18 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division.
      Published Date:
      February 12, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      Interim guidance for preventing the spread of coronavirus disease 2019 (COVID-19) in homes and residential communitiess[Chinese]本暂行指å—基于目å‰å·²çŸ¥çš„有关 2019 年新型冠状病毒 (2019-nCoV) 和其他病毒性呼å¸é“感染传播æ...
      File Type:
      Filetype[PDF - 135.18 KB]
    6. Filetype[PDF - 1.42 MB]
      Personal Author:
      Patel, Anita; Bell, Mike; De Perio, Marie;
      Corporate Authors:
      Centers for Disease Control and Prevention (U.S.)
      Published Date:
      February 11, 2020
      Description:
      Slides from the 55-minute webinar providing an overview of the coronavirus disease 2019 (COVID-19) response, how health systems can prepare, and strategies for optimizing supply of N95 respirators. They discuss actions and strategies to stop the spre...
      File Type:
      Filetype[PDF - 1.42 MB]
    7. Filetype[PDF - 93.09 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      February 18, 2020
      Description:
      Early detection, prevention, and control of Coronavirus Disease 2019 (COVID-19) on ships is important to protect the health of travelers on ships and to avoid transmission of the virus by disembarking passengers and crew members who are suspected of ...
      File Type:
      Filetype[PDF - 93.09 KB]
    8. Filetype[PDF - 76.12 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      February 18, 2020
      Description:
      Who is this for: Healthcare personnel who may care for patients who are confirmed with or under investigation for COVID-19.What is it for: This creates FAQs to support the existing Healthcare Infection Prevention and Control Guidance for COVID-19.How...
      File Type:
      Filetype[PDF - 76.12 KB]
    9. Filetype[PDF - 69.28 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      February 18, 2020
      Description:
      These infection prevention and control considerations are for healthcare facilities providing obstetric care for pregnant patients with confirmed coronavirus disease (COVID-19) or pregnant persons under investigation (PUI) in inpatient obstetric heal...
      File Type:
      Filetype[PDF - 69.28 KB]
    10. Filetype[PDF - 61.54 KB]
      Corporate Authors:
      National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Global Migration and Quarantine.
      Published Date:
      February 13, 2020
      Description:
      This document provides interim recommendations for the commercial airline industry about the Coronavirus Disease 2019 (COVID-19) first identified in Wuhan, China. CDC reminds air carriers of the requirement under Title 42 Code of Federal Regulations ...
      File Type:
      Filetype[PDF - 61.54 KB]
    11. Filetype[PDF - 46.40 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      February 19, 2020
      Description:
      This interim guidance is intended for women who are confirmed to have COVID-19 or are persons-under-investigation (PUI) for COVID-19 and are currently breastfeeding. This interim guidance is based on what is currently known about COVID-19 and the tra...
      File Type:
      Filetype[PDF - 46.40 KB]
    12. Filetype[PDF - 56.58 KB]
      Corporate Authors:
      Centers for Disease Control and Prevention (U.S.)
      Published Date:
      February 12, 2020
      Description:
      Updated February 12, 2020This interim guidance is for staff at local and state health departments, infection prevention and control professionals, and healthcare personnel who are coordinating the home care and isolation1 of people with confirmed or ...
      File Type:
      Filetype[PDF - 56.58 KB]
    13. Filetype[PDF - 502.49 KB]
      Corporate Authors:
      Centers for Disease Control and Prevention (U.S.)
      Published Date:
      February 19, 2020
      Description:
      On February 11, 2020 the World Health Organization announced an official name for the disease that is causing the current outbreak of coronavirus disease, COVID-19. CDC will be updating our website and other CDC materials to reflect the updated name....
      File Type:
      Filetype[PDF - 502.49 KB]
    14. Filetype[PDF - 73.51 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division.
      Published Date:
      February 18, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      Update: February 14, 2020(This guidance provides clarification regarding evaluation for home isolation and a new section with information regarding preventative steps for household members, intimate partners, and caregivers in a nonhealthcare setting...
      File Type:
      Filetype[PDF - 73.51 KB]

You May Also Like:

  1. Filetype[PDF - 69.28 KB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    February 18, 2020
    Description:
    These infection prevention and control considerations are for healthcare facilities providing obstetric care for pregnant patients with confirmed coronavirus disease (COVID-19) or pregnant persons under investigation (PUI) in inpatient obstetric heal...
    File Type:
    Filetype[PDF - 69.28 KB]
  2. Filetype[PDF - 46.40 KB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    February 19, 2020
    Description:
    This interim guidance is intended for women who are confirmed to have COVID-19 or are persons-under-investigation (PUI) for COVID-19 and are currently breastfeeding. This interim guidance is based on what is currently known about COVID-19 and the tra...
    File Type:
    Filetype[PDF - 46.40 KB]
  3. Filetype[PDF - 93.34 KB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    March 17, 2020
    Series:
    Coronavirus Disease 2019 (CoVID-19)
    Description:
    COVID-19 is a new disease and we are still learning how it spreads, the severity of illness it causes, and to what extent it may spread in the United States.
    File Type:
    Filetype[PDF - 93.34 KB]